Table 2.
Group | n | ALT (IU/L) | ALB (g/L) | GLB (g/L) | TG (mmol/L) | Liver HYP (μg/mg protein) |
Control | 15 | 67.58 ± 11.21 | 41.12 ± 2.54 | 21.48 ± 3.24 | 0.39 ± 0.08 | 9.80 ± 1.07 |
Model | 13 | 412 ± 94.50 | 28.49 ± 4.93 | 35.62 ± 3.28 | 0.95 ± 0.16 | 27.54 ± 4.32 |
High-dose | 12 | 173.09 ± 24.62bc | 35.73 ± 2.73a | 25.59 ± 3.61a | 0.61 ± 0.10b | 12.83 ± 2.54ad |
Medium-dose | 14 | 113.76 ± 14.91ad | 37.51 ± 3.17a | 24.82 ± 2.73a | 0.51 ± 0.06a | 16.20 ± 3.12bd |
Low-dose | 13 | 152.86 ± 19.19bc | 34.31 ± 4.52b | 27.51 ± 2.41b | 0.58 ± 0.07b | 14.38 ± 2.18bd |
ALT: Alanine aminotransferase; ALB: Albumin; GLB: Globulin; TG: Triglyeride; HYP: Hydroxyproline.
P < 0.05,
P < 0.01 vs control group;
P < 0.05,
P < 0.01 vs model group.